Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy

Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy

The U.S. government said Tuesday it negotiated a 71 percent discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for patients in Medicare, the federal health insurance program for the elderly.

15 high-cost drugs, including Ozempic, get major Medicare price reductions in latest negotiation round

A wave of vital prescription drugs is about to get a lot cheaper for people on Medicare. The Trump administration announced Tuesday that it has successfully negotiated lower prices for 15 drugs, including medications used for asthma, diabetes, arthritis, and multiple forms of cancer. The list includes Ozempic and Wegovy, Novo Nordisk’s drugs for Type 2 diabetes and weight management, as well as Rybelsus, the company’s oral GLP-1 for treating dia…

US negotiates for lower Ozempic drug prices

A negotiation between the US government and the federal Medicare program could lead to lower prices for certain medicines in the next few years.

Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy

The U.S. government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for patients in Medicare, the federal health insurance program for the elderly.

Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy

The U.S. government said this week it negotiated a 71 percent discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for patients in Medicare, the federal health insurance program for the elderly.

Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy

The U.S. government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for patients in Medicare, the federal health insurance program for the elderly. Read more...